GlassScriptPhysician profile
Nader N Helmi
NPI 1932376407
$24,574.57
in general payments reported to CMS, 2019-2025
25 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,113 · 2020: $9,140 · 2021: $7,835 · 2022: $1,345 · 2023: $1,168 · 2024: $893 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,777 · Travel and Lodging: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,777.02 |
| Travel and Lodging | $364.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,608.88 | 2019-2023 | Coveredge 32, Wavewriter Alpha Prime 16, Bionic Navigator |
| Abbott Laboratories | $5,396.76 | 2019-2025 | Proclaim, Eterna, Octrode |
| Vertiflex, INC. | $1,889.54 | 2019 | |
| Medtronic, INC. | $466.37 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Relievant Medsystems, INC. | $155.27 | 2022 | |
| Pfizer INC. | $136.65 | 2019 | |
| Stryker Corporation | $136.02 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $134.16 | 2025 | |
| Nevro Corp. | $111.35 | 2019-2021 | |
| Karyopharm Therapeutics INC. | $97.50 | 2020 | |
| Spr Therapeutics, INC | $57.05 | 2024-2025 | Sprint Pns System |
| Globus Medical, INC. | $56.95 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.25 | 2020-2024 | Relistor |
| Abbvie INC. | $44.89 | 2023-2025 | |
| Assertio Therapeutics, INC. | $40.15 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $38.96 | 2020-2024 | Prolate, Nalocet |
| Avanos Medical | $25.01 | 2024 | Generator |
| Medtronic USA, INC. | $23.28 | 2020 | |
| Scilex Pharmaceuticals INC. | $22.60 | 2019 | |
| Nalu Medical, INC. | $18.81 | 2025 | Nalu Neurostimulation System |
| Astrazeneca Pharmaceuticals LP | $16.23 | 2020 | |
| Si-Bone, INC. | $14.34 | 2024 | |
| Collegium Pharmaceutical, INC. | $13.14 | 2019 | |
| Biodelivery Sciences International, INC. | $12.23 | 2019 | |
| Stratus Medical, LLC | $10.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nader Helmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.